ADAM17: An Emerging Therapeutic Target for Lung Cancer

Lung cancer is the leading cause of cancer-related mortality, which histologically is classified into small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC accounts for approximately 85% of all lung cancer diagnoses, with the majority of patients presenting with lung adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Mohamed I., Rose-John, Stefan, Jenkins, Brendan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769596/
https://www.ncbi.nlm.nih.gov/pubmed/31438559
http://dx.doi.org/10.3390/cancers11091218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769596/
https://www.ncbi.nlm.nih.gov/pubmed/31438559
http://dx.doi.org/10.3390/cancers11091218

Ejemplares similares